Snibe diagnostic secures four new invention patents

Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe Diagnostic) recently secured four invention patent certificates, three from the China National Intellectual Property Administration and one from the Federal Service for Intellectual Property of Russia. The patents cover innovations in diagnostic technologies, further enhancing the company's research and development capabilities.

The newly granted Chinese patents include "Detection Reagents, Kits, and Methods for Latex Immunoturbidimetry," "Washing Module and Sample Analyzer Thereof," and "A Luminol Derivative and Its Preparation Method and Use." The latex immunoturbidimetry patent improves detection linearity and accuracy for high-concentration samples. The washing module patent enhances the accuracy of chemiluminescence immunoassay analyzers by preventing cross-contamination. The luminol derivative patent significantly boosts luminescence intensity, improving the sensitivity of chemiluminescence immunoassay platforms.

Additionally, a Russian patent was granted for "Biological Sample Experimental Status Display Method, Device and Biological Sample Analysis System." This patent provides a real-time monitoring and precise tracking solution for sample experimental status in the Molecision R8 automatic nucleic acid detection analysis system, improving the convenience of status inquiries. While Snibe Diagnostic stated these patents will not materially impact its current operations, they are expected to strengthen its intellectual property system and overall soft power.